responsable de laboratoire :Franck Callardo
Franck Gallardo, PhD, Founder&President, Scientific manager
Kerstin Bystricky, PhD/Professor, associate, scientific counsel
Bernard Mariamé, PhD, associate, scientific counsel
Bruno Brisson, M.sc, associate, external business developer (World), BLS consulting.
Hicham Saad, PhD, business developer (North America).
Franck Gallardo, PhD.
Président/CEO, NeoVirTech, SAS
Institut des Technologies Avancées en sciences du Vivant
1 place Pierre Potier, Oncopole, entrée B
31106 Toulouse
+33582991012
Who we are : NeoVirTech is an award winning biotechnology company localized at the heart of the Oncopole in Toulouse, France. The company combines custom R&D platform and screening services for the development of autofluorescent viruses or viral vectors and their use in screening campaign for the discovery of antiviral molecules for human and animal infections. NeoVirTech customers include academic laboratories, biotechnology companies and large pharmaceutical industries. The company capitalizes on its exclusive worldwide license for the ANCHORTM technology, a new generation of fluorescent DNA tagging system, which allows direct imaging of viral infection and replication in living cells. NeoVirTech won the Innovative Company Award from the French Ministry of Higher Education and Research as well as The French Agency for Innovation (BPI France) in 2013 and was nominated in 2015. NeoVirTech was also selected at the worldwide innovation contest in 2016.
_ What we do : NeoVirTech has developed unique screening models for the discovery of compounds with antiviral properties applied in human and animal health. NeoVirTech holds the first Herpesvirus with an autonomous and replicating autofluorescent viral DNA. We offer various types of services : A screening service providing high content information for the discovery or repositioning of molecules in anti-infective therapy : using a model virus whose fluorescence is proportional to the replication rate of viral DNA in order to prioritize the molecules according to their antiviral potential, their dose-response effects, and their toxicity. Custom autofluorescent virus development service providing a custom autofluorescent viral model in which the replication of virus can be monitored in real time by the use of the ANCHOR™ A sub-license program to acquire fluorescent native virus technology for internal use.
For informations,contact us.
DNA dynamics during early double-strand break processing revealed by non-intrusive imaging of living cells. Saad H, Gallardo F, Dalvai M, Tanguy-le-Gac N, Lane D, Bystricky K. PLoS Genet. 2014 Mar 13 ;10(3):e1004187. doi : 10.1371/journal.pgen.1004187.